Recent years, the outbreaks of emerging infectious diseases have become increasingly frequent, imposed unparalleled challenges on global public health. The COVID-19 pandemic, for example, rapidly spread globally, causing widespread health crises. Meanwhile, antimicrobial resistance (AMR), the “silent epidemic” is also severe. It is intensifying, threatening human health and medical system. It not only increases the difficulty of treating infections but also may trigger serious complications. Coping with emerging infectious diseases are becoming the urgent task in the global public health field. In this thesis, metal-based drug development has emerged as a crucial research field, offering substantial potential for effective solutions.
Funding
Research Grants Council (17318322, SRFS21227S04, T11-709/21N, 17306323,R7070-18,17308921,17304343)
ITF (ITS/278/20) of Hong Kong SAR
The University of Hong Kong (URC and Norman & Cecilia Yip Foundation)